CSIMarket Company Name, Ticker, Competitors, else..
 
Biolife Solutions Inc   (NASDAQ: BLFS)
 

Biolife Solutions Inc's Suppliers Performance

BLFS's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
BLFS Costs vs Sales of Suppliers Growth Biolife Solutions Inc recorded an increase in cost of sales by 26.68 % year on year, sequentially cost of sales grew by 1.79 % in Q2.

• More on BLFS Suppliers



Biolife Solutions Inc recorded increase in cost of sales by 26.68 % year on year, sequentially cost of sales grew by 1.79 % in Q2.

• More on BLFS Suppliers




Biolife Solutions Inc's Comment on Supply Chain


The company holds a US FDA Type II Master File for its biopreservation products, which are utilized in clinical trials. Its proprietary biopreservation media, including HypoThermosol FRS and CryoStor technologies, are formulated to reduce cellular damage during hypothermic and cryogenic storage by optimizing ionic balances and supplying regenerative substrates. These products are fully defined, serum-free, protein-free, and manufactured using USP/Multi-compendial grade or high-quality synthetic components through aseptic processing. This distinguishes them from competing products that often contain animal serum or single sugars and are designed for normothermic conditions rather than low temperatures.

Biolife Solutions Inc's Comment on Supply Chain


The company holds a US FDA Type II Master File for its biopreservation products, which are utilized in clinical trials. Its proprietary biopreservation media, including HypoThermosol FRS and CryoStor technologies, are formulated to reduce cellular damage during hypothermic and cryogenic storage by optimizing ionic balances and supplying regenerative substrates. These products are fully defined, serum-free, protein-free, and manufactured using USP/Multi-compendial grade or high-quality synthetic components through aseptic processing. This distinguishes them from competing products that often contain animal serum or single sugars and are designed for normothermic conditions rather than low temperatures.







BLFS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Biolife Solutions Inc 1,860.38 102.72 57.98 155
SUBTOTAL 0.00 0.00 0.00 -


Sources: Biolife Solutions Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Biolife Solutions Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.